BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nasr I, Nasr I, Beyers C, Chang F, Donnelly S, Ciclitira PJ. Recognising and Managing Refractory Coeliac Disease: A Tertiary Centre Experience. Nutrients 2015;7:9896-907. [PMID: 26633478 DOI: 10.3390/nu7125506] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
Number Citing Articles
1 Chetcuti Zammit S, Sanders DS, Sidhu R. Refractory coeliac disease: what should we be doing different? Curr Opin Gastroenterol 2020;36:215-22. [PMID: 32073508 DOI: 10.1097/MOG.0000000000000628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
2 Soderquist CR, Bhagat G. Cellular and molecular bases of refractory celiac disease. Int Rev Cell Mol Biol 2021;358:207-40. [PMID: 33707055 DOI: 10.1016/bs.ircmb.2020.12.001] [Reference Citation Analysis]
3 Cichewicz AB, Mearns ES, Taylor A, Boulanger T, Gerber M, Leffler DA, Drahos J, Sanders DS, Thomas Craig KJ, Lebwohl B. Diagnosis and Treatment Patterns in Celiac Disease. Dig Dis Sci. 2019;. [PMID: 30820708 DOI: 10.1007/s10620-019-05528-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 5.7] [Reference Citation Analysis]
4 Woodward J. Improving outcomes of refractory celiac disease - current and emerging treatment strategies. Clin Exp Gastroenterol 2016;9:225-36. [PMID: 27536154 DOI: 10.2147/CEG.S87200] [Cited by in Crossref: 21] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
5 Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, Fasano A. Celiac disease: a comprehensive current review. BMC Med. 2019;17:142. [PMID: 31331324 DOI: 10.1186/s12916-019-1380-z] [Cited by in Crossref: 137] [Cited by in F6Publishing: 117] [Article Influence: 45.7] [Reference Citation Analysis]
6 Forbes A. Immunosuppressants and immune modulators in luminal gastroenterology. Best Pract Res Clin Gastroenterol 2021;54-55:101759. [PMID: 34874843 DOI: 10.1016/j.bpg.2021.101759] [Reference Citation Analysis]
7 Baggus EMR, Hadjivassiliou M, Cross S, Penny H, Urwin H, Watson S, Woodward JM, Sanders DS. How to manage adult coeliac disease: perspective from the NHS England Rare Diseases Collaborative Network for Non-Responsive and Refractory Coeliac Disease.Frontline Gastroenterol. 2020;11:235-242. [PMID: 32419915 DOI: 10.1136/flgastro-2019-101191] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
8 Soderquist CR, Lewis SK, Gru AA, Vlad G, Williams ES, Hsiao S, Mansukhani MM, Park DC, Bacchi CE, Alobeid B, Green PH, Bhagat G. Immunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II. Am J Surg Pathol 2021;45:905-16. [PMID: 33544565 DOI: 10.1097/PAS.0000000000001658] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Poon SH, Stoddart L. Unexpected Cause of Rhabdomyolysis and Proximal Muscle Weakness. Arthritis Care Res (Hoboken) 2017;69:1599-605. [PMID: 28118531 DOI: 10.1002/acr.23200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Nasr I, Nasr I, Campling H, Ciclitira PJ. Approach to patients with refractory coeliac disease. F1000Res 2016;5:F1000 Faculty Rev-2544. [PMID: 27803799 DOI: 10.12688/f1000research.9051.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
11 Soderquist CR, Hsiao S, Mansukhani MM, Alobeid B, Green PH, Bhagat G. Refractory celiac disease type II: An atypical case highlighting limitations of the current classification system. Hematol Oncol 2020;38:399-405. [PMID: 32010998 DOI: 10.1002/hon.2720] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]